• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Torgeby Johan bought $705,880 worth of shares (14,000 units at $50.42), increasing direct ownership by 165% to 22,466 units (SEC Form 4)

    10/25/23 4:02:10 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance
    Get the next $NDAQ alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Torgeby Johan

    (Last) (First) (Middle)
    151 W. 42ND STREET

    (Street)
    NEW YORK NY 10036

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    NASDAQ, INC. [ NDAQ ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    10/23/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.01 per share 10/23/2023 P 14,000 A $50.42 22,466(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents (i) 8,466 shares or units of restricted stock granted pursuant to Nasdaq's Equity Incentive Plan, of which 3,324 are vested as of the date hereof and (ii) 14,000 shares of common stock acquired through open market purchases.
    Remarks:
    /s/ Alex Kogan, by power of attorney 10/25/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $NDAQ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NDAQ

    DatePrice TargetRatingAnalyst
    4/17/2025$91.00Neutral → Buy
    Redburn Atlantic
    4/8/2025$74.00Overweight → Equal-Weight
    Morgan Stanley
    1/8/2025$80.00 → $98.00Hold → Buy
    Deutsche Bank
    11/25/2024Outperform
    William Blair
    10/14/2024$82.00Mkt Perform → Outperform
    Raymond James
    9/27/2024$88.00Outperform
    RBC Capital Mkts
    9/26/2024$83.00Hold
    TD Cowen
    9/9/2024$78.00 → $80.00Outperform
    Oppenheimer
    More analyst ratings

    $NDAQ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nasdaq Announces Results from 2025 Annual Meeting of Shareholders

      All 12 Nominated Directors Elected Nasdaq Board Re-elects Adena T. Friedman as Chair of the Board NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (NASDAQ:NDAQ) shareholders elected all nominated directors at the company's Annual Meeting of Shareholders on Wednesday, June 11, 2025. All directors will serve one-year terms. The elected board members are: Melissa M. Arnoldi, EVP and General Manager for Business Solutions, AT&T Inc.Charlene T. Begley, Retired SVP and CIO, General Electric CompanyAdena T. Friedman, Chair and CEO, NasdaqEssa Kazim, Governor, Dubai International Financial CentreThomas A. Kloet, Retired CEO and Executive Director, TMX Group LimitedKathryn A. Koch, Presi

      6/16/25 4:30:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Delisting of Securities of Blue Star Foods Corp.; Altamira Therapeutics Ltd.; Evergreen Corporation; Fresh2 Group Limited; Coliseum Acquisition Corp.; The Real Good Food Company, Inc.; Mynaric AG; byNordic Acquisition Corporation; Avinger Inc.; MultiMetaVerse Holdings Limited; Nature's Miracle Holding Inc.; and SPI Energy Co., Ltd. from the Nasdaq Stock Market

      NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Blue Star Foods Corp. Blue Star Foods Corp.'s stock was suspended on December 20, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common shares of Altamira Therapeutics Ltd. Altamira Therapeutics Ltd.'s stock was suspended on December 20, 2024 and has not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the American Depositary Shares of Fresh2 Group Limited. Fresh2 Group Limited's stock was suspended on December 24, 2024 and has not traded on Nasdaq since that time. Nasdaq also

      6/11/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 30, 2025

      NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 30, 2025, short interest in 3,184 Nasdaq Global MarketSM securities totaled 13,504,275,894 shares compared with 13,735,568,588 shares in 3,168 Global Market issues reported for the prior settlement date of May 15, 2025. The mid-May short interest represents 2.19 days compared with 2.41 days for the prior reporting period. Short interest in 1,632 securities on The Nasdaq Capital MarketSM totaled 2,610,068,615 shares at the end of the settlement date of May 30, 2025, compared with 2,731,907,808 shares in 1,639 securities for the previous reporting period. This represents a 1.00 day average daily volume; the

      6/10/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $NDAQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Splinter Michael R was granted 5,241 shares, increasing direct ownership by 2% to 217,422 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      6/13/25 4:30:48 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Director Begley Charlene T was granted 2,995 shares, increasing direct ownership by 7% to 49,001 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      6/13/25 4:29:47 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Director Kloet Thomas A was granted 4,549 shares, increasing direct ownership by 17% to 32,005 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      6/13/25 4:28:49 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance